Quick Answer
Ascendis Pharma A/S reported Total Assets of $1.30 billion for the year ending 2025.
- Ascendis Pharma A/S showed an increase of +10.4% in Total Assets from 2024 to 2025.
- This data is from Ascendis Pharma A/S's annual report (Form 10-K), filed with the SEC on February 11, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), Ascendis Pharma A/S's Total Assets has grown by 585.3%.
- Historical annual values: Fiscal year 2025: $1.30 billion | Fiscal year 2024: $1.18 billion | Fiscal year 2023: $825.59 million | Fiscal year 2022: $1.09 billion | Fiscal year 2021: $1.08 billion | Fiscal year 2020: $979.79 million | Fiscal year 2019: $676.73 million | Fiscal year 2018: $318.97 million | Fiscal year 2017: $210.98 million | Fiscal year 2016: $190.07 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: